FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010114516> ?p ?o ?g. }

• W2010114516 endingPage "88" @default.
• W2010114516 startingPage "81" @default.
• W2010114516 abstract "Attenuated mutant strains of herpes simplex virus (HSV) have been effectively used for treatment of malignant brain tumors. As HSV-1 can infect and lyse a variety of cell types, other malignancies may also benefit from such treatment. We sought to test the feasibility of HSV-1 mutant-mediated gene therapy treatment of ovarian cancer.We prepared two attenuated mutant HSV-1 strains. An HSV-1 mutant, hrR3, has replaced the gene encoding ribonucleotide reductase (RR) with the lacZ reporter gene. We also developed a new replication-competent HSV-1 mutant, HR522; this virus, expressing the lacZ reporter gene, induces syncytium formation in infected cells. We compared the efficacy of HR522 with, paclitaxel (Taxol) and hrR3 in the treatment of nude mice harboring human ovarian cancer cells. We also examined the effect of the prodrug ganciclovir (GCV) on the treatment mediated by these HSVs. Survival was evaluated by Kaplan-Meier method and log-rank test.The survival of mice treated with a high-titer hrR3 (5 x 10(7) plaque-forming units [PFU]) was significantly prolonged as compared with the group given paclitaxel (P < 0.0001, log-rank test). Although the survival of mice treated with high-titer HR522 (5 x 10(7) PFU) was not significantly prolonged compared with paclitaxel-treated group (P = 0.212, log-rank test), GCV markedly enhanced the efficacy of HR522 administration (P < 0.005, vs paclitaxel, log-rank test). The lacZ gene product, visualized using 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-gal) histochemistry, was detected in HR522-treated tumors in areas also exhibiting apoptotic changes.These findings indicate that the combination of HR522 and GCV possesses significant therapeutic potential for treatment of ovarian cancer. Such viral therapy offers a novel approach to reductions in the dissemination of ovarian cancer." @default.
• W2010114516 created "2016-06-24" @default.
• W2010114516 creator A5023840133 @default.
• W2010114516 creator A5026489595 @default.
• W2010114516 creator A5046855564 @default.
• W2010114516 creator A5051009202 @default.
• W2010114516 creator A5058903905 @default.
• W2010114516 creator A5071439913 @default.
• W2010114516 creator A5072859215 @default.
• W2010114516 creator A5076276952 @default.
• W2010114516 creator A5077479682 @default.
• W2010114516 date "2003-10-01" @default.
• W2010114516 modified "2023-10-10" @default.
• W2010114516 title "Oncolytic viral therapy for human ovarian cancer using a novel replication-competent herpes simplex virus type I mutant in a mouse model" @default.
• W2010114516 cites W1558969188 @default.
• W2010114516 cites W1559374697 @default.
• W2010114516 cites W1571748845 @default.
• W2010114516 cites W1684170753 @default.
• W2010114516 cites W179303711 @default.
• W2010114516 cites W1926535247 @default.
• W2010114516 cites W1933198004 @default.
• W2010114516 cites W1965189214 @default.
• W2010114516 cites W1968566356 @default.
• W2010114516 cites W1970212185 @default.
• W2010114516 cites W1976128207 @default.
• W2010114516 cites W1990419055 @default.
• W2010114516 cites W1998830972 @default.
• W2010114516 cites W2000467533 @default.
• W2010114516 cites W2004897289 @default.
• W2010114516 cites W2021423477 @default.
• W2010114516 cites W2031688775 @default.
• W2010114516 cites W2036113828 @default.
• W2010114516 cites W2037605675 @default.
• W2010114516 cites W2054590955 @default.
• W2010114516 cites W2064203915 @default.
• W2010114516 cites W2072749711 @default.
• W2010114516 cites W2094234775 @default.
• W2010114516 cites W2108451948 @default.
• W2010114516 cites W2125831899 @default.
• W2010114516 cites W2144026922 @default.
• W2010114516 cites W2150804824 @default.
• W2010114516 cites W2291060081 @default.
• W2010114516 cites W2325605933 @default.
• W2010114516 doi "https://doi.org/10.1016/s0090-8258(03)00417-7" @default.
• W2010114516 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14529666" @default.
• W2010114516 hasPublicationYear "2003" @default.
• W2010114516 type Work @default.
• W2010114516 sameAs 2010114516 @default.
• W2010114516 citedByCount "17" @default.
• W2010114516 countsByYear W20101145162012 @default.
• W2010114516 countsByYear W20101145162014 @default.
• W2010114516 countsByYear W20101145162016 @default.
• W2010114516 countsByYear W20101145162020 @default.
• W2010114516 countsByYear W20101145162022 @default.
• W2010114516 countsByYear W20101145162023 @default.
• W2010114516 crossrefType "journal-article" @default.
• W2010114516 hasAuthorship W2010114516A5023840133 @default.
• W2010114516 hasAuthorship W2010114516A5026489595 @default.
• W2010114516 hasAuthorship W2010114516A5046855564 @default.
• W2010114516 hasAuthorship W2010114516A5051009202 @default.
• W2010114516 hasAuthorship W2010114516A5058903905 @default.
• W2010114516 hasAuthorship W2010114516A5071439913 @default.
• W2010114516 hasAuthorship W2010114516A5072859215 @default.
• W2010114516 hasAuthorship W2010114516A5076276952 @default.
• W2010114516 hasAuthorship W2010114516A5077479682 @default.
• W2010114516 hasConcept C104292427 @default.
• W2010114516 hasConcept C104317684 @default.
• W2010114516 hasConcept C108215921 @default.
• W2010114516 hasConcept C111599444 @default.
• W2010114516 hasConcept C121608353 @default.
• W2010114516 hasConcept C126322002 @default.
• W2010114516 hasConcept C143065580 @default.
• W2010114516 hasConcept C150194340 @default.
• W2010114516 hasConcept C153911025 @default.
• W2010114516 hasConcept C159047783 @default.
• W2010114516 hasConcept C161733203 @default.
• W2010114516 hasConcept C2522874641 @default.
• W2010114516 hasConcept C2777292972 @default.
• W2010114516 hasConcept C2777965375 @default.
• W2010114516 hasConcept C2779820661 @default.
• W2010114516 hasConcept C2780427987 @default.
• W2010114516 hasConcept C2781196997 @default.
• W2010114516 hasConcept C32611913 @default.
• W2010114516 hasConcept C4710235 @default.
• W2010114516 hasConcept C502942594 @default.
• W2010114516 hasConcept C55493867 @default.
• W2010114516 hasConcept C71924100 @default.
• W2010114516 hasConcept C82210918 @default.
• W2010114516 hasConcept C86803240 @default.
• W2010114516 hasConcept C98274493 @default.
• W2010114516 hasConceptScore W2010114516C104292427 @default.
• W2010114516 hasConceptScore W2010114516C104317684 @default.
• W2010114516 hasConceptScore W2010114516C108215921 @default.
• W2010114516 hasConceptScore W2010114516C111599444 @default.
• W2010114516 hasConceptScore W2010114516C121608353 @default.
• W2010114516 hasConceptScore W2010114516C126322002 @default.
• W2010114516 hasConceptScore W2010114516C143065580 @default.
• W2010114516 hasConceptScore W2010114516C150194340 @default.

• next